Research is ongoing to improve the efficacy and safety of anthracyclines. This includes the development of liposomal formulations that can reduce cardiotoxicity and enhance drug delivery to tumors. Additionally, combining anthracyclines with targeted therapies and immunotherapy holds promise for more effective cancer treatment with fewer side effects.
